Annual EBIT
-$8.66 M
+$2.21 M+20.32%
December 1, 2023
Summary
- As of February 7, 2025, REVB annual earnings before interest & taxes is -$8.66 million, with the most recent change of +$2.21 million (+20.32%) on December 1, 2023.
- REVB annual EBIT is now -110.85% below its all-time high of $79.77 million, reached on December 1, 2019.
Performance
REVB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.80 M
+$725.70 K+28.77%
September 1, 2024
Summary
- As of February 7, 2025, REVB quarterly earnings before interest & taxes is -$1.80 million, with the most recent change of +$725.70 thousand (+28.77%) on September 1, 2024.
- Over the past year, REVB quarterly EBIT has increased by +$725.70 thousand (+28.77%).
- REVB quarterly EBIT is now -49.79% below its all-time high of -$1.20 million, reached on September 30, 2022.
Performance
REVB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$8.55 M
+$981.20 K+10.30%
September 1, 2024
Summary
- As of February 7, 2025, REVB TTM earnings before interest & taxes is -$8.55 million, with the most recent change of +$981.20 thousand (+10.30%) on September 1, 2024.
- Over the past year, REVB TTM EBIT has increased by +$981.20 thousand (+10.30%).
- REVB TTM EBIT is now -227.76% below its all-time high of -$2.61 million, reached on March 31, 2021.
Performance
REVB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
REVB EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.3% | +28.8% | +10.3% |
| 3 y3 years | - | +28.8% | +10.3% |
| 5 y5 years | -114.2% | +28.8% | +10.3% |
REVB EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.6% | -49.8% | +72.7% | -44.9% | +46.3% |
| 5 y | 5-year | -110.8% | +27.6% | -49.8% | +72.7% | -227.8% | +46.3% |
| alltime | all time | -110.8% | +27.6% | -49.8% | +72.7% | -227.8% | +46.3% |
Revelation Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.80 M(-28.8%) | -$8.55 M(-10.3%) |
| Jun 2024 | - | -$2.52 M(+32.6%) | -$9.53 M(+6.6%) |
| Mar 2024 | - | -$1.90 M(-18.2%) | -$8.94 M(+3.3%) |
| Dec 2023 | -$8.66 M(-20.3%) | -$2.33 M(-16.3%) | -$8.66 M(+14.7%) |
| Sep 2023 | - | -$2.78 M(+43.7%) | -$7.55 M(+26.4%) |
| Jun 2023 | - | -$1.93 M(+19.3%) | -$5.97 M(+1.2%) |
| Mar 2023 | - | -$1.62 M(+33.0%) | -$5.90 M(-45.7%) |
| Dec 2022 | -$10.86 M | -$1.22 M(+1.6%) | -$10.86 M(-19.5%) |
| Sep 2022 | - | -$1.20 M(-35.5%) | -$13.50 M(-12.0%) |
| Jun 2022 | - | -$1.86 M(-71.8%) | -$15.35 M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.59 M(+70.8%) | -$15.93 M(+33.3%) |
| Dec 2021 | -$11.95 M(-115.0%) | -$3.86 M(+26.7%) | -$11.95 M(+47.7%) |
| Sep 2021 | - | -$3.04 M(+24.7%) | -$8.09 M(+60.3%) |
| Jun 2021 | - | -$2.44 M(-6.4%) | -$5.05 M(+93.6%) |
| Mar 2021 | - | -$2.61 M | -$2.61 M |
| Dec 2019 | $79.77 M(+30.4%) | - | - |
| Dec 2018 | $61.18 M(+31.9%) | - | - |
| Dec 2017 | $46.38 M(+88.7%) | - | - |
| Dec 2016 | $24.58 M(+60.8%) | - | - |
| Dec 2015 | $15.29 M | - | - |
FAQ
- What is Revelation Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Revelation Biosciences?
- What is Revelation Biosciences annual EBIT year-on-year change?
- What is Revelation Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Revelation Biosciences?
- What is Revelation Biosciences quarterly EBIT year-on-year change?
- What is Revelation Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Revelation Biosciences?
- What is Revelation Biosciences TTM EBIT year-on-year change?
What is Revelation Biosciences annual earnings before interest & taxes?
The current annual EBIT of REVB is -$8.66 M
What is the all time high annual EBIT for Revelation Biosciences?
Revelation Biosciences all-time high annual earnings before interest & taxes is $79.77 M
What is Revelation Biosciences annual EBIT year-on-year change?
Over the past year, REVB annual earnings before interest & taxes has changed by +$2.21 M (+20.32%)
What is Revelation Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of REVB is -$1.80 M
What is the all time high quarterly EBIT for Revelation Biosciences?
Revelation Biosciences all-time high quarterly earnings before interest & taxes is -$1.20 M
What is Revelation Biosciences quarterly EBIT year-on-year change?
Over the past year, REVB quarterly earnings before interest & taxes has changed by +$725.70 K (+28.77%)
What is Revelation Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of REVB is -$8.55 M
What is the all time high TTM EBIT for Revelation Biosciences?
Revelation Biosciences all-time high TTM earnings before interest & taxes is -$2.61 M
What is Revelation Biosciences TTM EBIT year-on-year change?
Over the past year, REVB TTM earnings before interest & taxes has changed by +$981.20 K (+10.30%)